Promising preclinical data for ASTH-A768 now in Communications Medicine
24 January 2025
The preclinical data supporting ASTH-A768, one of our most advanced assets, is now available in…
Health~Holland Grant boosts research for ASO therapies
17 December 2024
Our team has been awarded a grant from the Top Sector Life Sciences & Health…
Co-founder Carel Hoyng honoured with Dutch Medical Retina Award
15 November 2024
Today, our co-founder, Prof. dr. Carel Hoyng, will be giving a special talk at the…
Leadership transition that continues driving our mission
1 October 2024
Our CEO, Berno Maaswinkel, will be stepping down as he faces personal circumstances that make…
CSO Rob Collin opens 5th Gene Therapy Summit in Boston
9 September 2024
On Wednesday, September 11, Astherna’s Chief Scientific Officer, Prof. Rob Collin, will open Day 1…
Our CSO keynotes at Dutch Antisense Therapeutics Symposium
22 May 2024
Our Chief Scientific Officer, Prof. dr. Rob Collin, will be a keynote speaker at the…